Lake Street Capital Boosts Evogene (NASDAQ:EVGN) Price Target to $3.00 : vimarsana.com

Evogene (NASDAQ:EVGN – Free Report) had its target price lifted by Lake Street Capital from $2.00 to $3.00 in a research note released on Friday morning, MarketBeat.com reports. They currently have a buy rating on the biotechnology company’s stock. EVGN has been the topic of several other research reports. StockNews.com initiated coverage on Evogene in […]

Related Keywords

Roth Mkm , Silverarc Capital Management , Evogene Company Profile , Vident Investment Advisory , Evogene Ltd , Human Health , Renaissance Technologies , Virtu Financial , Free Report , Lake Street Capital , Get Free Report , Investment Advisory , Capital Management , Computational Predictive Biology , Evogene Daily , Evogene , Nasdaq Evgn , Evgn , Medical , Boost Price Target ,